Pharmaceutical Technology, April 2023

As new manufacturing processes and technologies are introduced to meet demand and overcome challenges, understanding also needs to improve to ensure the right balance is achieved.

Despite the advantages intensified processes can offer developers, there are still some obstacles to overcome before broader application of new technologies will be implemented.

Impurities and batch-to-batch variability present the biggest challenges.

Limitations in production platforms have impeded continuous manufacturing for advanced therapies.

Manufacturers and suppliers join forces to reduce the pharmaceutical industry’s carbon footprint.

Alternative approaches to freeze-drying are gaining popularity and will help to overcome some of the challenges associated with conventional lyophilization.

Considering the differences between small- and large-molecule drug products can help determine analytical testing methods for E&L.

Contract testing services demonstrate a major increase in the speed and efficiency of testing using new testing methods and technologies.

New child-friendly treatment options and initiatives are improving the outlook of children living with HIV in Europe.

FDA has spurred investment to create and develop 600 therapies.

Proposed regulatory changes signal a major overhaul of legislation governing pharmaceuticals and healthcare in Spain.

A risk assessment should be performed as part of the CAPA process, says Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates.

What can we take away from Pfifzer's acquisition of Seagen?

A further setback to the publication of the pharmaceutical legislative changes in Europe may mean time is running out for appropriate review before 2024 parliamentary elections.

Direct-to-consumer drug advertising has developed as a cottage industry which has been used to increase prescriptions immensely.

The ROSS Model CDA-200 is fitted with multiple agitators for semi-continuous operation.

The Thermo Fisher Scientific Nicolet Summit X FTIR Spectrometer is a high-performance system designed for flexibility, ease of use, and high productivity.

Bio-Rad Laboratories StarBright Blue and StarBright Yellow dyes are conjugated to flow validated antibodies, supporting flow cytometry panel design in immunology design.

Bio-Rad Laboratories StarBright Blue and StarBright Yellow dyes are conjugated to flow validated antibodies, supporting flow cytometry panel design in immunology design.